Most ‘GLP-1 Nonresponders’ Never Get a Fair Shot
I see this pattern every week. A patient is 12 weeks into semaglutide therapy. They’ve lost 2%-3% of…
Are Sexual Side Effects Emerging With GLP-1 Agonists?
Few new drugs have sparked as much interest and as many questions as GLP-1 agonists. Originally developed to…
Does Intermittent Fasting Improve Cardiometabolic Health?
A new study calls into question the effectiveness of time-restricted eating (TRE) in producing measurable improvements in metabolic…